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A number of basic concepts underlie this presen- 
tation. First, the development, natural history, and 
clinical history of all pathology are strongly influ- 
enced by an individual's genotype; hence all com- 
mon disorders are hereditary to some degree. Any 
pathologic ondition can be defined by distinct con- 
cepts: its etiology and its pathogenesis. Etiology is 
the study of cause, while pathogenesis is the process 
through which causal agents affect the clinical phe- 
notype. Risk factors are quantitative traits, either 
continuous or discrete, that provide some indepen- 
dent prediction of the likelihood that an individual 
will develop a specific disease. Risk factors, which 
can be deleterious or protective, are determined by 
epidemiologic studies of populations and may indi- 
cate a specific contributor to causation or pathogen- 
esis, or may be a somewhat remote marker for such 
agents. Pathogcnetic factors derive from the study of 
biologic phenomena; the more precisely a pheno- 
type is defined (eg, coronary atherosclerosis v  angi- 
na pectoris), the more relevant o an individual the 
pathogenetic factor should be. Factors that define 
both risk and pathogenesis are often classified as 
genetic or environmental, but this is a false dichoto- 
my. Increasingly, how an individual responds to spe- 
cific encounters in the environment is recognized as 
defined by the genotype. 
Much of our understanding of risk factors for 
atherosclerosis has derived from research on the clin- 
ical consequences of atherosclerosis, such as myocar- 
dial infarction and stroke. Thus, factors that predis- 
pose to, or protect from, acute thrombosis, equelae 
ofischemia, tissue repair, and so forth may have epi- 
demiologic importance to clinicians but minimal rel- 
evance to the understanding of atherosclerosis. 
This presentation reviews genetic factors that 
influence the cause and pathogenesis ofatherosclero- 
sis, the clinical consequences of which account for 
around 40% of deaths in the developed world. The 
traditional risk factors are shown in the following list. 
Epidemiologic Risk Factors for Atherosclerosis 
• Age 
• Gender 
• Estrogen deficiency 
• Cigarette smoking (> 10 per day) 
• Physical inactivity 
• Diabetes mcllitus, type I and type II 
• Hypertension 
• Abdominal obesity 
• Family history of atherosclerotic disease in a 
relative less than 55 years old 
• Dyslipidemia 
high total serum cholesterol 
high LDL  cholesterol 
low HDL cholesterol 
high triglycerides 
high Lp(a) 
Especially worthy of mention for several reasons is 
the family history. The lower the age criterion for 
determining whether the risk factor is positive or not, 
the more powerful it is for the fewer probands who 
will be defined as positive. Also, in population studies, 
the family history remains predictive ven when all of 
the other factors with strong genetic contributions 
(lipids, diabetes, hypertension) are accounted for. 
Research in the past decade has focused more on 
overt or possible pathogenetic factors, based on 
improved understanding of atherogenesis and vascu- 
lar biology. Some of these factors are summarized in
the next fist. 
Pathogenetic Factors for Atherosclerosis 
• LDL cholesterol 
LDL receptor defects 
hyperapolipoprotein B 
• dense LDL particles 
• oxidized LDL particles 
• HDL cholesterol 
hypo- and hyperlipoprotein A1
• Hyperinsulinemia and insulin resistance 
• Hyperglycemia ([3-glycosylation of extracel- 
lular matrix components) 
• Homocysteine 
deficiency of cystathioninc b-synthase or 
methionine synthetase 
methylene tetrahydrofolate reductase 
(deficiency or thermolabile variant) 
gene-environment i eractions (deficiency of 
folate, B6, and B12) 
• Vascular geometry (lesions develop at branch 
points due to variations in turbulence) 
Determining which probands with clinical mani- 
festations of atherosclerosis have a strong genetic 
contribution to their underlying disease is relatively 
straightforward and precise based on current capa- 
bilities (blood markers, pedigree analysis). The same 
holds for predicting risk in near relatives of 
probands. Some of the risk factors with strong 
genetic bases can be managed quite successfully by 
current approaches of diet and lifestyle modifica- 
tions. Advanced understanding of vascular pathobi- 
ology will undoubtedly soon add to the list ofpatho- 
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genetic factors with a defined genetic cause, and 
improved methodology for genotyping will enable 
rapid and (perhaps) inexpensive identification of 
individuals with deleterious (and protective) mark- 
ers. The real challenge will be to: 
* perform outcome studies to determine the 
relative importance of specific genes and 
alleles; 
• identify means to modulate the risks of spe- 
cific alleles; and 
• perform intervention trials to prove the 
clinical utility of both the tests and the 
interventions. 
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Mutations in the gene for fibrillin-1 have been 
implicated as etiologic in aneurysms associated with 
Marfan syndrome, but thc hereditary risk factors for 
more common aneurysmal conditions affecting the 
cerebral arteries and the aorta are uncertain. The 
present discussion will focus on the abdominal aor- 
tic aneurysm (AAA). 
The stereotype of the AAA patient is an aging 
white male smoker with a positive family history for 
the disease. A recent ultrasound screening study of 
the siblings ofAAA probands reaffirms this profile, 
with the three leading risk factors being male sex 
(12x increased risk), family history (4x increased 
risk), and age (2x increased risk). 1 Another large 
scale screening study of 73,451 American veterans 
had similar confirmatory data. The three leading 
"positive" risk factors for AAAs of 3.0 to 3.9 cm 
were smoldng, family history, and age (with odds 
ratios of 2.72, 1.96, and 1.52, respectively); and the 
three leading "negative" risk factors were female 
sex, diabetes, and black race (with odds ratios of 
0.62, 0.68, and 0.72, respectively). 2 It is possible 
that additional associations of AAA (for example, 
with inguinal hernia 3 nd with elongation of the 
internal carotid artery) 4 might also reflect heredi- 
tary risk factors. 
Several candidate genes have been considered and 
rejected by our group and others. Mutation in the 
gene for procollagen III cosegregated with AAA dis- 
ease in one family, 5 but further studies revealed that 
mutation of this gene is an infrequent cause of AAA 
in a larger population. 6 We reported apolymorphism 
of the gene for TIMP-1 in two of six AAA patients, 
but the transition was in the third position of the 
codon. The encoded amino acid was unchanged. The 
role, if any, for deficiency alleles of alpha-1 antitrypsin 
is unclear.7 
Considering that much recent evidence points to a 
role for autoimmunity in AAA degeneration, our 
group reported MHC Class II DR typing on a small 
group of North Americans (26) of mixed descent. 
Eighty-one percent of these individuals had a DR allele 
with phenylalanJne residues at positions 31 and 47 of 
the second hypervariable region; 35% had a double 
dose of a putative susceptibility allele. 7 HLA DR-15 is 
one of the alleles 7 with the above characteristics, and
HLA DR-15 has been implicated in a North American 
population of patients with inflammatory AAA. 8 In 
the more homogeneous population of Japan, DR-15 
was detected in 59% of 46 AAA patients versus 28% of 
50 control subjects. 9 Further study of this population 
suggested that HLA-DQ3 had a protective effect. 
If DR-15 positive and DQ-3 negative are the 
high-risk serotypes, then 89% of 36 AAA patients 
had one or both of these features, as compared with 
41% of 39 control subjects, l0 
Although genes among structural matrix pro- 
teins, proteinases, and proteinase inhibitors have 
been the leading candidates todate, the possible role 
of HLA DR and DQ genes merits more study. 
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